Lynge, Denmark, February 23, 2026 — WSA, a leading pure-play hearing healthcare group, today announced that Harrison Boyd has been appointed President Region Americas and a member of the Executive Committee, effective March 9, 2026.
Mr. Boyd is joining WSA from Abbott Laboratories, where he led the commercial organization for Endovascular and Coronary. Prior to Abbott, he held multiple leadership positions at CSI, ultimately serving as Vice President and General Manager of the U.S. Harrison's work history includes leadership roles at Zoll Cardiac Management Solutions and Boehringer Ingelheim, building on his experience in the pharmaceutical sector.
WSA CEO Jan Makela said:
"We are thrilled that Harrison will be joining WSA to lead our Americas region. His extensive experience in senior leadership roles across many healthcare industries will be a great asset to our company. We look forward to working with him and warmly welcome him to the company and our Executive Committee."
